Litcius/Paper detail

A review on tyrosine kinase inhibitors for targeted breast cancer therapy

Vidya Sankarapandian, Ramya Lakshmi Rajendran, Conrad Ondieki Miruka, Sivamani Poornima, Balu Alagar Venmathi Maran, Rajapandiyan Krishnamoorthy, Prakash Gangadaran, Byeong‐Cheol Ahn

2024Pathology - Research and Practice23 citationsDOIOpen Access PDF

Topics & Concepts

Tyrosine kinaseBreast cancerMedicineCancer therapyCancer researchTargeted therapyCancerOncologyTyrosine-kinase inhibitorInternal medicinePharmacologyReceptorHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesPI3K/AKT/mTOR signaling in cancer
A review on tyrosine kinase inhibitors for targeted breast cancer therapy | Litcius